[News] Carcinogenicity of atrazine, alachlor, and vinclozolin

The Lancet Oncology | |

From October to November, 2025, a Working Group of 22 scientists from 12 countries met at the International Agency for Research on Cancer (IARC) in Lyon, France, to finalise their evaluation of the carcinogenicity of atrazine, alachlor, and vinclozolin.

Topics: cervical-cancer, research